BEAM THERAPEUTICS INC. - COMMON STOCK

Beam Therapeutics to Participate in the Guggenheim Genomic Medicines and Rare Disease Conference

25 مارس 2022 05:30:00 بحسب Nasdaq GlobeNewswire

Beam Therapeutics to Participate in the Barclays 2022 Global Healthcare Conference

08 مارس 2022 05:30:00 بحسب Nasdaq GlobeNewswire

Beam Therapeutics Reports Pipeline and Business Highlights, Planned 2022 Milestones and Fourth Quarter and Full Year 2021 Financial Results

28 فبراير 2022 05:30:00 بحسب Nasdaq GlobeNewswire

Beam Therapeutics to Present at the SVB Leerink 11th Annual Global Healthcare Conference

09 فبراير 2022 05:30:00 بحسب Nasdaq GlobeNewswire

Pfizer and Beam Enter Exclusive Multi-Target Research Collaboration to Advance Novel In Vivo Base Editing Programs for a Range of Rare Diseases

10 يناير 2022 05:00:00 بحسب Nasdaq GlobeNewswire

Beam Therapeutics Reports Progress Across Ex Vivo and In Vivo Pipeline of Base Editing Therapeutics and Outlines Key Anticipated 2022 Milestones

09 يناير 2022 08:00:00 بحسب Nasdaq GlobeNewswire

Beam Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference

03 يناير 2022 05:30:00 بحسب Nasdaq GlobeNewswire

Beam Therapeutics Outlines Long-term Strategy for Base Editing Programs in Sickle Cell Disease and Provides Preclinical Data Updates at ASH

12 ديسمبر 2021 08:00:00 بحسب Nasdaq GlobeNewswire

Beam Therapeutics Reports Preclinical Data Highlighting Multiplex Base Editing Approach to Create Anti-CD5 CAR T-cell Investigational Therapies for T-Cell Malignancies

12 نوفمبر 2021 06:00:02 بحسب Nasdaq GlobeNewswire

Beam Therapeutics to Participate in the Jefferies 2021 Virtual London Healthcare Conference

11 نوفمبر 2021 05:30:00 بحسب Nasdaq GlobeNewswire

Beam Therapeutics Provides Business and Pipeline Updates and Reports Third Quarter 2021 Financial Results

08 نوفمبر 2021 05:00:00 بحسب Nasdaq GlobeNewswire

Beam Therapeutics Appoints Healthcare Industry Leader John Maraganore, Ph.D., to its Board of Directors

08 نوفمبر 2021 05:00:00 بحسب Nasdaq GlobeNewswire

Beam Therapeutics Announces Upcoming Preclinical Data Presentations at the American Society of Hematology Annual Meeting

04 نوفمبر 2021 08:40:00 بحسب Nasdaq GlobeNewswire

Beam Therapeutics to Participate in the Jefferies Gene Therapy/Editing Summit

20 أكتوبر 2021 05:30:00 بحسب Nasdaq GlobeNewswire

Beam Therapeutics Announces Preclinical Data Highlighting Base Editing Approach to Correct a Glycogen Storage Disease Type Ia Disease-Causing Mutation

19 أكتوبر 2021 05:30:00 بحسب Nasdaq GlobeNewswire

Beam Therapeutics to Present Preclinical Data Highlighting Potential of CAR T Multiplex Base Editing Approach Targeting CD5 at 2021 SITC Annual Meeting

01 أكتوبر 2021 07:43:59 بحسب Nasdaq GlobeNewswire

Beam Therapeutics to Participate in the Chardan Virtual 5th Annual Genetic Medicines Conference

28 سبتمبر 2021 05:30:00 بحسب Nasdaq GlobeNewswire

Beam Therapeutics Announces Updated Preclinical Data Highlighting Optimized LNP Delivery Approaches for In Vivo Base Editing to the Liver and Other Tissues

23 سبتمبر 2021 05:30:00 بحسب Nasdaq GlobeNewswire

Beam Therapeutics to Participate in the 2021 Wells Fargo Virtual Healthcare Conference

08 سبتمبر 2021 05:30:00 بحسب Nasdaq GlobeNewswire

Beam Therapeutics Provides Business and Pipeline Updates and Reports Second Quarter 2021 Financial Results

10 أغسطس 2021 05:30:00 بحسب Nasdaq GlobeNewswire